Suppr超能文献

肌肽对肥胖心脏的抗纤维化作用基于其对铁的清除及对胶原蛋白交联的抑制。

Iron scavenging and suppression of collagen cross-linking underlie antifibrotic effects of carnosine in the heart with obesity.

作者信息

Berdaweel Islam A, Monroe T Blake, Alowaisi Amany A, Mahoney Jolonda C, Liang I-Chau, Berns Kaitlyn A, Gao Dylan, McLendon Jared M, Anderson Ethan J

机构信息

Department of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, University of Iowa, Iowa City, IA, United States.

Department of Clinical Pharmacy, College of Pharmacy, Yarmouk University, Irbid, Jordan.

出版信息

Front Pharmacol. 2024 Jan 3;14:1275388. doi: 10.3389/fphar.2023.1275388. eCollection 2023.

Abstract

Oral consumption of histidyl dipeptides such as l-carnosine has been suggested to promote cardiometabolic health, although therapeutic mechanisms remain incompletely understood. We recently reported that oral consumption of a carnosine analog suppressed markers of fibrosis in liver of obese mice, but whether antifibrotic effects of carnosine extend to the heart is not known, nor are the mechanisms by which carnosine is acting. Here, we investigated whether oral carnosine was able to mitigate the adverse cardiac remodeling associated with diet induced obesity in a mouse model of enhanced lipid peroxidation (i.e., glutathione peroxidase 4 deficient mice, GPx4), a model which mimics many of the pathophysiological aspects of metabolic syndrome and T2 diabetes in humans. Wild-type (WT) and GPx4male mice were randomly fed a standard (CNTL) or high fat high sucrose diet (HFHS) for 16 weeks. Seven weeks after starting the diet, a subset of the HFHS mice received carnosine (80 mM) in their drinking water for duration of the study. Carnosine treatment led to a moderate improvement in glycemic control in WT and GPx4mice on HFHS diet, although insulin sensitivity was not significantly affected. Interestingly, while our transcriptomic analysis revealed that carnosine therapy had only modest impact on global gene expression in the heart, carnosine substantially upregulated cardiac GPx4 expression in both WT and GPx4mice on HFHS diet. Carnosine also significantly reduced protein carbonyls and iron levels in myocardial tissue from both genotypes on HFHS diet. Importantly, we observed a robust antifibrotic effect of carnosine therapy in hearts from mice on HFHS diet which further experiments suggest is due to carnosine's ability to suppress collagen-cross-linking. Collectively, this study reveals antifibrotic potential of carnosine in the heart with obesity and illustrates key mechanisms by which it may be acting.

摘要

口服组氨酸二肽(如L-肌肽)已被认为可促进心脏代谢健康,尽管其治疗机制仍未完全明确。我们最近报道,口服一种肌肽类似物可抑制肥胖小鼠肝脏中的纤维化标志物,但肌肽的抗纤维化作用是否能扩展到心脏尚不清楚,其作用机制也不明了。在此,我们研究了在脂质过氧化增强的小鼠模型(即谷胱甘肽过氧化物酶4缺陷小鼠,GPx4)中,口服肌肽是否能够减轻与饮食诱导的肥胖相关的不良心脏重塑,该模型模拟了人类代谢综合征和2型糖尿病的许多病理生理特征。野生型(WT)和GPx4雄性小鼠被随机给予标准(对照)饮食或高脂肪高蔗糖饮食(HFHS)16周。在开始饮食7周后,一部分HFHS小鼠在研究期间饮用含肌肽(80 mM)的水。肌肽治疗使HFHS饮食的WT和GPx4小鼠的血糖控制有适度改善,尽管胰岛素敏感性未受到显著影响。有趣的是,虽然我们的转录组分析显示肌肽疗法对心脏中的整体基因表达只有适度影响,但肌肽在HFHS饮食的WT和GPx4小鼠中均显著上调了心脏GPx4的表达。肌肽还显著降低了HFHS饮食的两种基因型小鼠心肌组织中的蛋白质羰基和铁水平。重要的是,我们观察到肌肽疗法对HFHS饮食小鼠的心脏有强大的抗纤维化作用,进一步的实验表明这是由于肌肽抑制胶原交联的能力。总的来说,这项研究揭示了肌肽在肥胖心脏中的抗纤维化潜力,并阐明了其可能的关键作用机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/896f/10859874/662d11a261bc/fphar-14-1275388-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验